Pregnancy in Hypertrophic Cardiomyopathy with Severe Left Ventricular Outflow Tract Obstruction

Jaeouk Shin1, Minsu Kim1, Junsoo Lee1

  • 1Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, Korea.; Gachon Cardiovascular Research Institute, Gachon University, Incheon, Korea.

Insights

Pregnant patients with severe hypertrophic obstructive cardiomyopathy (HOCM) face high risks. Close monitoring and management are crucial for successful delivery in these high-risk HOCM pregnancies.

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) poses significant risks during pregnancy, particularly severe left ventricular outflow tract (LVOT) obstruction (>100 mm Hg).
  • Pregnancy-induced physiological changes can exacerbate HOCM, leading to serious maternal and fetal complications like sudden cardiac death, heart failure, and arrhythmias.

Observation:

  • A 27-year-old pregnant patient at 34 weeks gestation presented with severe HOCM and a resting LVOT pressure gradient (PG) of 125 mm Hg, increasing to 152 mm Hg with Valsalva maneuver.
  • This case highlights the critical need for vigilant monitoring and tailored management strategies in pregnant individuals with extremely high LVOT obstruction.

Findings:

  • Close echocardiographic monitoring and appropriate medical management facilitated a successful delivery.
  • The case demonstrates that even with extremely high pressure gradients, favorable maternal and fetal outcomes are achievable.

Implications:

  • This case underscores the importance of multidisciplinary care for pregnant patients with severe HOCM.
  • Effective management strategies can mitigate risks and improve outcomes for both mother and fetus in high-risk pregnancies involving HOCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
416
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
508
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K